awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35677661-F5897024-7F8A-4461-A981-EF2E57E51078
Q35677661-F5897024-7F8A-4461-A981-EF2E57E51078
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35677661-F5897024-7F8A-4461-A981-EF2E57E51078
A phase I trial of vertical inhibition of IGF signalling using cixutumumab, an anti-IGF-1R antibody, and selumetinib, an MEK 1/2 inhibitor, in advanced solid tumours.
P2860
Q35677661-F5897024-7F8A-4461-A981-EF2E57E51078
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35677661-F5897024-7F8A-4461-A981-EF2E57E51078
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3d6158dc60f161e88d39ae580b0f3a1702c59cfa
P2860
The IGF-I receptor in cancer research.